2018 National Viral Hepatitis Progress Report
The National Viral Hepatitis Progress Report provides information on seven data indicators, providing an objective way to assess progress toward achieving key viral hepatitis goals.
The National Viral Hepatitis Progress Report provides information on seven data indicators, providing an objective way to assess progress toward achieving key viral hepatitis goals.
In this video CDC's Dr. LoBue discussing the updated recommendations for the 12-dose treatment regimen for latent TB infection.
A new report from the National Academy of Public Administration that makes the case for taking urgent, concrete action to address skyrocketing STDs in the United States.
This report evaluates the current needs, protocols, and promising practices for latent tuberculosis infection (LTBI) and tuberculosis (TB) screening, testing, and treatment among community health centers serving Asian American/Asian (A/AA) and Native Hawaiian/Pacific Islander (NH/PI) populations.
This webpage explains Assembly Bill 2132, which mandates tuberculosis (TB) risk assessment and testing for adult primary care patients in California.
This journal discusses a case of tertiary syphilis leading to ocular syphilis and complications such as retinal detachment. It highlights the diagnostic challenges, treatment approaches, and clinical implications of late-stage syphilis affecting the eyes.
This webpage explores the treatment of Hepatitis C (HCV) and HIV coinfection, addressing the complexities of managing both infections simultaneously. It discusses antiviral treatment options, potential drug interactions, and strategies for monitoring and managing the dual conditions effectively.